Pages that link to "Q34102002"
Jump to navigation
Jump to search
The following pages link to Amphetamine toxicities: classical and emerging mechanisms. (Q34102002):
Displaying 50 items.
- Toxicity of amphetamines: an update (Q22252794) (← links)
- Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine (Q23916279) (← links)
- Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum (Q24621938) (← links)
- Neurologic manifestations of chronic methamphetamine abuse (Q24624506) (← links)
- Impact of methamphetamine on infection and immunity (Q26829217) (← links)
- Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine (Q27320548) (← links)
- Neuroimmune basis of methamphetamine toxicity (Q28247084) (← links)
- Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology (Q28260273) (← links)
- Vesicular integrity in Parkinson's disease (Q28385737) (← links)
- Interleukin 1 receptor contributes to methamphetamine- and sleep deprivation-induced hypersomnolence (Q28389929) (← links)
- The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations (Q28397865) (← links)
- Protective role for the disulfide isomerase PDIA3 in methamphetamine neurotoxicity (Q28484171) (← links)
- Illicit stimulant use is associated with abnormal substantia nigra morphology in humans (Q28486143) (← links)
- Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction (Q28486981) (← links)
- Hand function is altered in individuals with a history of illicit stimulant use (Q28542886) (← links)
- Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis (Q28543389) (← links)
- Distributed attentional deficits in chronic methamphetamine abusers: evidence from the Attentional Network Task (ANT) (Q30381226) (← links)
- Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. (Q30511888) (← links)
- Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure (Q30538147) (← links)
- Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain (Q30624704) (← links)
- Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum (Q33580523) (← links)
- Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. (Q33583474) (← links)
- Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (Q33638542) (← links)
- Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity (Q33702977) (← links)
- Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction (Q33703726) (← links)
- Methamphetamine-mediated modulation of MOR expression in the SH-SY5Y neuroblastoma cell line (Q33817198) (← links)
- Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure. (Q33878485) (← links)
- The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine (Q34025177) (← links)
- Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate (Q34183952) (← links)
- Complex role of zinc in methamphetamine toxicity in vitro (Q34209487) (← links)
- The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum (Q34281043) (← links)
- Methamphetamine influences on brain and behavior: unsafe at any speed? (Q34282453) (← links)
- Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? (Q34318601) (← links)
- A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus. (Q34372437) (← links)
- Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats (Q34428204) (← links)
- Methamphetamine reduces human influenza A virus replication (Q34471943) (← links)
- Altitude may contribute to regional variation in methamphetamine use in the United States: a population database study (Q34476477) (← links)
- Enhanced brain distribution of modified aspartoacylase (Q34616189) (← links)
- Human Ecstasy use is associated with increased cortical excitability: an fMRI study. (Q34820201) (← links)
- Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report (Q34843459) (← links)
- Contributions of serotonin in addiction vulnerability (Q35032325) (← links)
- A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity (Q35058866) (← links)
- Extended access methamphetamine decreases immature neurons in the hippocampus which results from loss and altered development of neural progenitors without altered dynamics of the S-phase of the cell cycle (Q35242144) (← links)
- Impaired Formation of Stimulus–Response, But Not Action–Outcome, Associations in Rats with Methamphetamine-Induced Neurotoxicity (Q35356625) (← links)
- Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction (Q35529280) (← links)
- Mitochondria: key players in the neurotoxic effects of amphetamines. (Q35572468) (← links)
- Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval (Q35589685) (← links)
- Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. (Q35688532) (← links)
- Psychostimulant addiction treatment (Q35915231) (← links)
- Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain (Q36158723) (← links)